Junko Nagai

In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599

Yuji Iizawa, Junko Nagai, Tomoyasu Ishikawa et al. · Journal of Infection and Chemotherapy · 2004 · 84 citations

Vivo Anti-mrsa Activity, Antibiotics, Medicine +10

Atopic dermatitis successfully treated by eradication of Helicobacter pylori.

Kazunari Murakami, Toshiyuki Fujioka, Akira Nishizono et al. · PubMed · 1996 · 39 citations

Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database

Yusuke Kan, Junko Nagai, Yoshihiro Uesawa · Scientific Reports · 2021 · 38 citations · Full text

Quantitative Structure–Cytotoxicity Relationship of 2-Styrylchromones

Yoshihiro Uesawa, Junko Nagai, Haixia Shi et al. · Anticancer Research · 2019 · 36 citations · Full text

2-Styrylchromone derivatives as potent and selective monoamine oxidase B inhibitors

Koichi Takao, Saki Endo, Junko Nagai et al. · Bioorganic Chemistry · 2019 · 32 citations

2-Styrylchromone Derivatives, Medicinal Chemistry, Biochemistry +9